334 related articles for article (PubMed ID: 22752869)
1. Predictors of first recurrence of Clostridium difficile infection: implications for initial management.
Eyre DW; Walker AS; Wyllie D; Dingle KE; Griffiths D; Finney J; O'Connor L; Vaughan A; Crook DW; Wilcox MH; Peto TE;
Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S77-87. PubMed ID: 22752869
[TBL] [Abstract][Full Text] [Related]
2. Clinical predictors of recurrent Clostridium difficile infection in out-patients.
Shivashankar R; Khanna S; Kammer PP; Scott Harmsen W; Zinsmeister AR; Baddour LM; Pardi DS
Aliment Pharmacol Ther; 2014 Sep; 40(5):518-22. PubMed ID: 25039269
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.
Freedberg DE; Salmasian H; Friedman C; Abrams JA
Am J Gastroenterol; 2013 Nov; 108(11):1794-801. PubMed ID: 24060760
[TBL] [Abstract][Full Text] [Related]
4. Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials.
Baggs J; Yousey-Hindes K; Ashley ED; Meek J; Dumyati G; Cohen J; Wise ME; McDonald LC; Lessa FC
Vaccine; 2015 Nov; 33(46):6241-9. PubMed ID: 26450660
[TBL] [Abstract][Full Text] [Related]
5. Outcomes in community-acquired Clostridium difficile infection.
Khanna S; Pardi DS; Aronson SL; Kammer PP; Baddour LM
Aliment Pharmacol Ther; 2012 Mar; 35(5):613-8. PubMed ID: 22229532
[TBL] [Abstract][Full Text] [Related]
6. Five years experience of Clostridium difficile infection in children at a UK tertiary hospital: proposed criteria for diagnosis and management.
Pai S; Aliyu SH; Enoch DA; Karas JA
PLoS One; 2012; 7(12):e51728. PubMed ID: 23300561
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology of Clostridium difficile infection in children: a population-based study.
Khanna S; Baddour LM; Huskins WC; Kammer PP; Faubion WA; Zinsmeister AR; Harmsen WS; Pardi DS
Clin Infect Dis; 2013 May; 56(10):1401-6. PubMed ID: 23408679
[TBL] [Abstract][Full Text] [Related]
8. Influence of antibiotics and case exposure on hospital-acquired Clostridium difficile infection independent of illness severity.
Forster AJ; Daneman N; van Walraven C
J Hosp Infect; 2017 Apr; 95(4):400-409. PubMed ID: 27825674
[TBL] [Abstract][Full Text] [Related]
9. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors that Predict Recurrent Clostridium difficile Infections in Surgical Patients.
Messick CA; Hammel JP; Hull T
Am Surg; 2017 Jun; 83(6):653-659. PubMed ID: 28637570
[TBL] [Abstract][Full Text] [Related]
11. Clostridioides (Clostridium) difficile infection in Japanese hospitals 2008-2017: A real-world nationwide analysis of treatment pattern, incidence and testing density.
Kimura T; Stanhope S; Sugitani T
J Infect Chemother; 2020 May; 26(5):438-443. PubMed ID: 32081648
[TBL] [Abstract][Full Text] [Related]
12. Epidemiologic and Clinical Characteristics of Clostridioides difficile Infections in Hospitalized and Outpatient Pediatric Oncology and Hematopoietic Stem Cell Transplant Patients.
Barbar R; Hayden R; Sun Y; Tang L; Hakim H
Pediatr Infect Dis J; 2021 Jul; 40(7):655-662. PubMed ID: 34097657
[TBL] [Abstract][Full Text] [Related]
13. Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin.
Cornely OA; Miller MA; Louie TJ; Crook DW; Gorbach SL
Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S154-61. PubMed ID: 22752865
[TBL] [Abstract][Full Text] [Related]
14. Clostridioides difficile infection and recurrence among 2622 solid organ transplant recipients.
Schluger A; Rosenblatt R; Knotts R; Verna EC; Pereira MR
Transpl Infect Dis; 2019 Dec; 21(6):e13184. PubMed ID: 31571380
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Clostridium difficile infection severity in patients hospitalised in medical intensive care.
Khanafer N; Touré A; Chambrier C; Cour M; Reverdy ME; Argaud L; Vanhems P
World J Gastroenterol; 2013 Nov; 19(44):8034-41. PubMed ID: 24307797
[TBL] [Abstract][Full Text] [Related]
16. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
mBio; 2020 May; 11(3):. PubMed ID: 32371595
[No Abstract] [Full Text] [Related]
17. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.
Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS
Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474
[TBL] [Abstract][Full Text] [Related]
18. Time trends and predictors of laboratory-confirmed recurrent and severe
Shaffer SR; Nugent Z; Walkty A; Yu BN; Lix LM; Targownik LE; Bernstein CN; Singh H
CMAJ Open; 2020; 8(4):E737-E746. PubMed ID: 33199507
[TBL] [Abstract][Full Text] [Related]
19. Frequent hospital readmissions for Clostridium difficile infection and the impact on estimates of hospital-associated C. difficile burden.
Murphy CR; Avery TR; Dubberke ER; Huang SS
Infect Control Hosp Epidemiol; 2012 Jan; 33(1):20-8. PubMed ID: 22173518
[TBL] [Abstract][Full Text] [Related]
20. Multicenter study of Clostridium difficile infection rates from 2000 to 2006.
Dubberke ER; Butler AM; Yokoe DS; Mayer J; Hota B; Mangino JE; Khan YM; Popovich KJ; Fraser VJ
Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1030-7. PubMed ID: 20695799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
